How and when should we monitor chimerism after allogeneic stem cell transplantation?
P Bader, D Niethammer, A Willasch… - Bone marrow …, 2005 - nature.com
Chimerism analysis has become an important tool for the peri-transplant surveillance of
engraftment. It offers the possibility to realize impending graft rejection and can serve as an …
engraftment. It offers the possibility to realize impending graft rejection and can serve as an …
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses
R Childs, E Clave, N Contentin… - Blood, The Journal …, 1999 - ashpublications.org
Nonmyeloablative allogeneic stem cell transplantation has recently been explored as a
safer alternative to conventional high-dose transplant regimens. Although a high incidence …
safer alternative to conventional high-dose transplant regimens. Although a high incidence …
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell …
P Bader, H Kreyenberg, W Hoelle… - Journal of clinical …, 2004 - ascopubs.org
Purpose We recently reported that children with acute leukemias who show increasing
mixed chimerism (MC) after allogeneic stem-cell transplantation have a significantly …
mixed chimerism (MC) after allogeneic stem-cell transplantation have a significantly …
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR …
C Thiede, M Bornhäuser, U Oelschlägel, C Brendel… - Leukemia, 2001 - nature.com
Sequential analysis of chimerism after allogeneic blood stem cell transplantation (BSCT)
has been shown to be predictive for graft failure and relapse. We have explored the impact …
has been shown to be predictive for graft failure and relapse. We have explored the impact …
Bone marrow engraftment analysis after allogeneic bone marrow transplantation
VMD Van Deerlin, DGB Leonard - Clinics in laboratory medicine, 2000 - Elsevier
Bone marrow engraftment (BME) analysis of allogeneic bone marrow transplant (allo-BMT)
patients can detect residual recipient cells that survive the conditioning regimen. The results …
patients can detect residual recipient cells that survive the conditioning regimen. The results …
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
E Rettinger, AM Willasch, H Kreyenberg… - Blood, The Journal …, 2011 - ashpublications.org
Previous studies have shown that children with acute myeloid leukemia (AML) who
developed mixed chimerism (MC) were at high risk for relapse after allogeneic stem-cell …
developed mixed chimerism (MC) were at high risk for relapse after allogeneic stem-cell …
Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely …
J Dubovsky, H Daxberger, G Fritsch, D Printz, C Peters… - Leukemia, 1999 - nature.com
The monitoring of chimerism by PCR has become a routine diagnostic approach in patients
after allogeneic bone marrow or peripheral blood stem cell transplantation. Nevertheless, a …
after allogeneic bone marrow or peripheral blood stem cell transplantation. Nevertheless, a …
Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed …
P Bader, T Klingebiel, A Schaudt, U Theurer-Mainka… - Leukemia, 1999 - nature.com
The success of allogeneic stem cell transplantation (allo-SCT) in children is mainly affected
by relapse or graft rejection. We have recently shown in a study of 55 patients with acute …
by relapse or graft rejection. We have recently shown in a study of 55 patients with acute …
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik, J Aschan, O Ringden - Leukemia, 2001 - nature.com
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
[HTML][HTML] Comparison of chimerism and minimal residual disease monitoring for relapse prediction after allogeneic stem cell transplantation for adult acute …
TH Terwey, PG Hemmati, M Nagy, H Pfeifer… - Biology of Blood and …, 2014 - Elsevier
Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …